151 related articles for article (PubMed ID: 6130563)
1. beta-Endorphin, cortisol, and prolactin in serum of schizophrenic patients during long-term neuroleptic treatment and after withdrawal: relationships to psychopathology.
Naber D; Albus M; Muller F; Burke H; Welter D; Ackenheil M; Hippius H
Psychopharmacol Bull; 1982 Oct; 18(4):224-6. PubMed ID: 6130563
[No Abstract] [Full Text] [Related]
2. [Psychopathologic changes in chronic schizophrenic patients following withdrawal of neuroleptics: relation to therapeutic, neuroendocrine and computer tomography variables].
Albus M; Naber D; Ackenheil M; Bürke H; Müller-Spahn F; Münch U; Reinertshofer T; Schmidt-Vanderheyden W; Weber G; Wissmann J
Fortschr Neurol Psychiatr; 1986 Jan; 54(1):15-20. PubMed ID: 2868983
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of beta-endorphin under chronic neuroleptic treatment in schizophrenic patients: failure of naloxone to counteract curative effects of neuroleptic drugs.
Emrich HM; Höllt V; Bergmann M; Kissling W; Schmid W; Zerssen DV; Herz A
Adv Biochem Psychopharmacol; 1980; 22():489-502. PubMed ID: 6104902
[No Abstract] [Full Text] [Related]
4. Neuroleptic withdrawal in chronic schizophrenia: CT and endocrine variables relating to psychopathology.
Naber D; Albus M; Bürke H; Müller-Spahn F; Münch U; Reinertshofer T; Wissmann J; Ackenheil M
Psychiatry Res; 1985 Nov; 16(3):207-19. PubMed ID: 2868473
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrinological and biochemical effects of chronic neuroleptic treatment.
Hippius H; Ackenheil M; Müller-Spahn F
Adv Biochem Psychopharmacol; 1985; 40():9-13. PubMed ID: 2862769
[No Abstract] [Full Text] [Related]
6. Basal and stimulated levels of prolactin, TSH, and LH in serum of chronic schizophrenic patients long-term treated with neuroleptics: relations to psychopathology.
Naber D; Ackenheil M; Laakmann G
Adv Biochem Psychopharmacol; 1980; 24():419-23. PubMed ID: 6105792
[TBL] [Abstract][Full Text] [Related]
7. Naloxone treatment for five days ineffective in schizophrenia. Neuroendocrine actions of the opiate antagonist.
Naber D; Münch U; Wissmann J; Grosse R; Ritt R; Welter D
Acta Psychiatr Scand; 1983 Apr; 67(4):265-71. PubMed ID: 6305111
[No Abstract] [Full Text] [Related]
8. No correlation between neuroleptic-induced increase of beta-endorphin serum level and therapeutic efficacy in schizophrenia.
Naber D; Nedopil N; Eben E
Br J Psychiatry; 1984 Jun; 144():651-3. PubMed ID: 6146374
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of serotonergic response in treatment-refractory schizophrenia patients.
Lindenmayer JP; Adityanjee ; Vital-Herne M; Bark N; Grochowski S; Moynihan N
Biol Psychiatry; 1997 Jul; 42(1):6-12. PubMed ID: 9193736
[TBL] [Abstract][Full Text] [Related]
10. [Blood levels of beta-endorphins and the changes caused by neuroleptics in acute and chronic schizophrenics].
Barcia D; Martínez A; López L; Ruiz ME; Galiana M; Muñoz R; Huertas F
Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1984; 12(1):3-10. PubMed ID: 6144248
[No Abstract] [Full Text] [Related]
11. Tardive dyskinesia: relation to computer-tomographic, endocrine, and psychopathological variables.
Albus M; Naber D; Müller-Spahn F; Douillet P; Reinertshofer T; Ackenheil M
Biol Psychiatry; 1985 Oct; 20(10):1082-9. PubMed ID: 2864087
[TBL] [Abstract][Full Text] [Related]
12. Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patients.
Pickar D; Davis GC; Schulz SC; Extein I; Wagner R; Naber D; Gold PW; van Kammen DP; Goodwin FK; Wyatt RJ; Li CH; Bunney WE
Am J Psychiatry; 1981 Feb; 138(2):160-6. PubMed ID: 6257125
[TBL] [Abstract][Full Text] [Related]
13. Serum prolactin and smoking status in chronic antipsychotic-treated male patients with schizophrenia.
Zhang X; Bu R; Sha W; Wang X; Liu J; Chu X; Li J; Dong H; Liu Y; Qing J
Psychiatry Res; 2013 Sep; 209(2):239-41. PubMed ID: 23684052
[TBL] [Abstract][Full Text] [Related]
14. [Beta-endorphin concentration in the cerebrospinal fluid of schizophrenics].
Ignatov SA; Burbaeva GSh; Tsutsul'kovskaia MIa; Abramova LI; Trubnikov VI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(9):1331-7. PubMed ID: 6108032
[TBL] [Abstract][Full Text] [Related]
15. The effect of neuroleptic treatment and of high dosage diazepam therapy on beta-endorphin immunoreactivity in plasma of schizophrenic patients.
Gramsch C; Emrich HM; John S; Haas S; Beckmann H; Zaudig M; von Zerssen D
J Neural Transm; 1984; 59(2):133-41. PubMed ID: 6144724
[TBL] [Abstract][Full Text] [Related]
16. [The endorphin system and physical medicine].
Crielaard JM; Bastin R; Franchimont P
Acta Belg Med Phys; 1983; 6(4):141-5. PubMed ID: 6142576
[No Abstract] [Full Text] [Related]
17. Cytokine production in drug-free and neuroleptic-treated schizophrenic patients.
Bessler H; Levental Z; Karp L; Modai I; Djaldetti M; Weizman A
Biol Psychiatry; 1995 Sep; 38(5):297-302. PubMed ID: 7495923
[TBL] [Abstract][Full Text] [Related]
18. [Serum concentration of beta-endorphin in schizophrenic and depressive diseases].
Nagel S; Tegeler J; Goertz B
Nervenarzt; 1982 Nov; 53(11):659-63. PubMed ID: 6294535
[No Abstract] [Full Text] [Related]
19. Diurnal rhythms of plasma cortisol, beta-endorphin and prolactin, and cerebrospinal fluid amine metabolite levels before suicide. Case report.
Dent RR; Ghadirian AM; Kusalic M; Young SN
Neuropsychobiology; 1986; 16(2-3):64-7. PubMed ID: 2438587
[TBL] [Abstract][Full Text] [Related]
20. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.
Szymanski S; Lieberman J; Pollack S; Kane JM; Safferman A; Munne R; Umbricht D; Woerner M; Masiar S; Kronig M
Biol Psychiatry; 1996 Feb; 39(4):249-54. PubMed ID: 8645771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
